Health Products

Monolisa Hcv Ag-Ab Ultra V2

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Medical devices - Microbiology
Product: Monolisa Hcv Ag-Ab Ultra V2
Issue: Medical devices - Performance
What to do: Contact the manufacturer if you require additional information.
Audience: Healthcare
Recall class: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberModel or catalogue numberAffected products
3B1066
3A0065
72561Monolisa Hcv Ag-Ab Ultra V2

Issue

During an internal assessment, sensitivity to the HCV antigen was reduced for samples near the detection limit. Due to the reduced sensitivity of the HCV antigen test, recent infections by HCV cannot be detected in patient samples as early as with previous lots of Monolisa HCV Ag-Ab ULTRA V2. For these lots, there is no impact on the detection of seroconversions of antibodies against HCV.

Recall start date: December 1, 2023

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime